LAS VEGAS, March 2, 2018 /PRNewswire/ --
FN Media Group Presents Microcapspeculators.com News Commentary
As reported this week by the Indianapolis Star, Indiana may be the latest state to legalize cannabidiol oil, or CBD oil in the Hoosier state. The House unanimously passed Senate Bill 52, which would legalize CBD oil that contains only low-levels of THC. That is the component that at higher levels gives cannabis users a "high." Included in today's commentary: NightFood Holdings, Inc. (OTC: NGTF), GW Pharmaceuticals plc (NASDAQ: GWPH), INSYS Therapeutics, Inc. (NASDAQ: INSY), Terra Tech Corp. (OTC: TRTC), and General Cannabis Corp. (OTC: CANN).
If the measure clears a couple more hurdles, it could become law by late March.
Last legislative session lawmakers passed a bill to allow epileptic patients on a registry to purchase CBD oil.
The Senate is set to vote on two other CBD-related bills, including House Bill 1137, which would allow Hoosiers to grow low-THC hemp.
This is another great piece of news for the CBD industry.
Some companies making news in this industry include: NightFood Holdings, Inc. (OTC: NGTF), GW Pharmaceuticals plc (NASDAQ: GWPH), INSYS Therapeutics, Inc. (NASDAQ: INSY), Terra Tech Corp. (OTCQX: TRTC), and General Cannabis Corp. (OTCQB: CANN).
NightFood Holdings, Inc. (OTC: NGTF)
Market Cap: $17.59M, current share price: $.45
Innovative snack brand development company NightFood Holdings, Inc. (NGTF), announced that the Company has scheduled an investor conference call at 4:30 PM eastern standard time on Thursday, Mar 1st, 2018.
"It's been a very eventful and very successful three months for both NightFood and MJ Munchies," commented Company CEO Sean Folkson. "We respect the importance of open communication, and enjoy keeping investors up to date on Company developments through these ongoing quarterly calls."
GW Pharmaceuticals plc (NASDAQ: GWPH)
Market Cap: $3.05B, current share price: $108.95
GWPH, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, this week announced that the European Medicines Agency (EMA) has granted orphan drug designation for cannabidiol (CBD) for the treatment of tuberous sclerosis (TS). GW is currently recruiting a Phase 3 clinical trial of Epidiolex® (cannabidiol) as an adjunctive therapy for the treatment of seizures associated with TS, with data expected in the second half of 2018. Subject to positive results, GW expects to submit regulatory applications in 2019 for Epidiolex in TS in both the U.S. and Europe.
INSYS Therapeutics, Inc. (NASDAQ: INSY)
Market Cap: $533.15M, current share price: $7.27
INSY, a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, recently that company founder John N. Kapoor, Ph.D., has completed the previously announced formation of an independently controlled trust related to his ownership stake in the company. The trust has been publicly filed with the Securities and Exchange Commission by the company on a Current Report on Form 8-K.
Terra Tech Corp. (OTCQX: TRTC)
Market Cap: $233.74M, current share price: $.24
TRTC , a vertically integrated cannabis-focused agriculture company, this year received State of California Temporary Authorization to cultivate, non-volatile manufacture, of cannabis for adult use.
General Cannabis Corp. (OTCQB: CANN)
Market Cap: $111.76M, current share price: $3.33
CANN, the comprehensive resource for the highest quality service providers available to the regulated cannabis industry, announced the hiring of cannabis industry veteran Joe Hodas as Chief Operating Officer (COO). Leveraging his recent experience in helping drive Dixie Brands, Inc.'s national expansion efforts across multiple states and brand lines, Hodas will be responsible for driving revenue and efficiency across all of General Cannabis' (GC) existing lines of business, including: Iron Protection Group (security and cash transportation services); Chiefton (apparel and marketing consulting); and Next Big Crop (operations consulting and products), as well as General Cannabis' corporate infrastructure.
From an analysis of companies working with CBD and marijuana, there are many potential avenues for CBD to infiltrate the market.
Website: http://microcapspeculators.com/
For Full Legal Disclaimer Click Here.
DISCLAIMER: Microcapspeculators.com (MS) is the source of the content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM,) and its online brand FinancialNewsMedia.com, is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MS or any company mentioned herein. The commentary, views and opinions expressed in this release by MS are solely those of MS and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MS and FNM for any investment decisions by their readers or subscribers. MS and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks included herein by MS. FNM was not compensated by any public company mentioned herein to disseminate this press release on behalf of MS.
MS Disclosure: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC. which owns Microcapspeculators.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC. which owns, Microcapspeculators.com may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC. which owns Microcapspeculators.com may be compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MS and FNM undertake no obligation to update such statements.
Content Provided By: Microcap Speculators
Email: info@microcapspecualtors.com
Phone: +1-702-720-6310
Media Contact
FN Media Group LLC
e-mail: editor@financialnewsmedia.com
+1-(954)-345-0611
SOURCE Microcapspeculators.com
